Bio-Techne Corp
F:TE1

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
F:TE1
Watchlist
Price: 47.92 EUR -0.15% Market Closed
Market Cap: €7.6B

Wall St Price Targets

TE1 Price Targets Summary
Bio-Techne Corp

Wall Street analysts forecast TE1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TE1 is 77.43 EUR with a low forecast of 67.28 EUR and a high forecast of 86.09 EUR.

Lowest Forecast
Price Target
67.28 EUR
40% Upside
Average Forecast
Price Target
77.43 EUR
62% Upside
Highest Forecast
Price Target
86.09 EUR
80% Upside
Bio-Techne Corp Competitors:
Price Targets
AGCO
AGCO Corp
9% Upside
TPST
Tempest Therapeutics Inc
470% Upside
MRKR
Marker Therapeutics Inc
457% Upside
WEED
Canopy Growth Corp
55% Upside

Revenue
Forecast

11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 7%.

Operating Income
Forecast

3% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss
3% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

-3% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
-3% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 5 years is 44%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TE1's stock price target?
Price Target
77.43 EUR

According to Wall Street analysts, the average 1-year price target for TE1 is 77.43 EUR with a low forecast of 67.28 EUR and a high forecast of 86.09 EUR.

What is the Revenue forecast for Bio-Techne Corp?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 7%.

What is the Operating Income forecast for Bio-Techne Corp?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Bio-Techne Corp?
Projected CAGR
44%

Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 5 years is 44%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett